RecruitingNCT04367246
Rare condition
Li-Fraumeni syndrome
12
studies recruiting now
as of 7 Sept 2026
25
studies registered in total
as of 7 Sept 2026
8
countries with a recruiting site
as of 7 Sept 2026
21 Mar 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT01143454
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RecruitingNCT01443468
Clinical and Genetic Studies of Li-Fraumeni Syndrome
RecruitingNCT06888388
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
RecruitingNCT03050268
Familial Investigations of Childhood Cancer Predisposition
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 12 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Li-Fraumeni syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Li-Fraumeni syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (CDKN2A, MDM2, TP53, CHEK2).
Treatments being studied
1 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 1Metformin
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).